Quarterly Transactions Made in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC). The information is specifically focused on institutions that hold shares of Revance Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 2,236,177 | 8,215,825 | 10,452,002 | 3,118,729 | 392,911 | 3,511,640 | 6,940,362 | |
| Q4 2021 | 8,011,335 | 1,544,880 | 9,556,215 | 6,571,452 | 2,025,025 | 8,596,477 | 959,738 | |
| Q1 2022 | 3,048,833 | 1,501,884 | 4,550,717 | 2,587,757 | 185,865 | 2,773,622 | 1,777,095 | |
| Q2 2022 | 5,596,219 | 809,970 | 6,406,189 | 2,094,706 | 2,570,688 | 4,665,394 | 1,740,795 | |
| Q3 2022 | 13,612,205 | 4,414,890 | 18,027,095 | 5,245,500 | 159,166 | 5,404,666 | 12,622,429 | |
| Q4 2022 | 10,542,473 | 2,135,674 | 12,678,147 | 4,732,079 | 0 | 4,732,079 | 7,946,068 | |
| Q1 2023 | 9,203,166 | 2,165,240 | 11,368,406 | 6,540,212 | 0 | 6,540,212 | 4,828,194 | |
| Q2 2023 | 10,374,222 | 3,748,788 | 14,123,010 | 4,363,175 | 0 | 4,363,175 | 9,759,835 | |
| Q3 2023 | 11,318,982 | 3,491,727 | 14,810,709 | 10,192,602 | 0 | 10,192,602 | 4,618,107 | |
| Q4 2023 | 6,314,164 | 2,273,104 | 8,587,268 | 7,968,072 | 0 | 7,968,072 | 619,196 | |
| Q1 2024 | 13,771,676 | 8,048,170 | 21,819,846 | 5,436,157 | 0 | 5,436,157 | 16,383,689 | |
| Q2 2024 | 7,848,093 | 2,828,180 | 10,676,273 | 7,211,547 | 0 | 7,211,547 | 3,464,726 | |
| Q3 2024 | 11,221,797 | 33,525,464 | 44,747,261 | 16,454,441 | 135,788 | 16,590,229 | 28,157,032 | |